← Back to headlines
Rhythm Pharma down after late-stage trial setback for lead asset in rare obesity disorders
17 Mar, 10:59 — 17 Mar, 10:59
Sources
Showing 1 of 1 sources
Related Stories
ACPN backs Soludo’s drug reforms, local manufacturing drive
16m ago
Older mangrove woods for smoking fish contain high levels of cancer-causing agents – KNUST study
18m ago
Why your metabolism slows down after 30: Orthopaedic experts warn of ‘silent’ muscle and bone loss you can’t feel yet
23m ago
United Kingdom, national alarm for meningitis epidemic: 2 boys dead and 11 in serious condition
28m ago